Copyright
©The Author(s) 2024.
World J Transplant. Jun 18, 2024; 14(2): 91146
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.91146
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.91146
Variable | Results on arrival | Reference range |
White blood cell count (k/uL) | 6.45 | 4.50-11.00 |
Red blood cell count (M/uL) | 3.21 | 4.40-5.90 (male); 3.80-5.20 (female) |
Hemoglobin (g/dL) | 8.4 | 13.0-18.0 (male); 12.0-16.0 (female) |
Hematocrit (%) | 24.7 | 40.0-52.0 (male); 35.0-47.0 (female) |
MCV (fL) | 82.3 | 80.0-100.0 |
Platelet count (k/uL) | 131 | 150-440 |
ESR (mm/h) | 16 | < 20 |
CRP (mg/L) | 2.1 | < 5.0 |
Sodium (mEq/L) | 132 | 136-145 |
Potassium (mEq/L) | 4.4 | 3.4-4.4 |
Chloride (mEq/L) | 89 | 98-107 |
Bicarbonate (mEq/L) | 33 | 22-29 |
BUN (mg/dL) | 33 | 8-26 |
Creatinine (mg/dL) | 6.63 | 0.72-1.25 |
Ammonia (umol/L) | 12 | 18-72 |
Hemoglobin A1C (%) | 11.4 | 4.3-5.7 |
Tacrolimus level (ng/mL) | 20.6 (on admission) | 3-5 (goal therapeutic trough level in the late post-transplant phase) |
- Citation: Dilibe A, Subramanian L, Poyser TA, Oriaifo O, Brady R, Srikanth S, Adabale O, Bolaji OA, Ali H. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World J Transplant 2024; 14(2): 91146
- URL: https://www.wjgnet.com/2220-3230/full/v14/i2/91146.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i2.91146